Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ(R) MRD Testing into OncoEMR(R)
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ(R) MRD Testing into OncoEMR(R) GlobeNewswire July 01, 2025 SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and Flatiron […]